ELV vs PGNY
ELV: Elevance Health is a leading health benefits and services organization providing comprehensive medical, pharmacy, and integrated clinical care solutions to millions of members. PGNY: Progyny is a benefits platform that delivers superior fertility and women's health outcomes for employers through proprietary Smart Cycle treatment bundles, a selective specialist network, and integrated pharmacy services.
Side-by-side fundamentals
| Metric | ELV | PGNY | Edge |
|---|---|---|---|
| Price as of 2026-08-10 close | $397.70 | $27.85 | |
| Market cap as of 2026-08-11 | $86.2B | $2.1B | |
| P/E as of 2026-08-11 | 17.42 | 27.92 | ELV lower |
| PEG as of 2026-08-11 | 3.95 | 3.86 | PGNY lower |
| Net margin as of 2026-08-11 | +2.5% | +6.0% | PGNY higher |
| Gross margin as of 2026-08-11 | n/a | +24.6% | |
| Operating margin as of 2026-08-11 | +3.6% | +8.6% | PGNY higher |
| ROE as of 2026-08-11 | +11.2% | +16.0% | PGNY higher |
| ROA as of 2026-08-11 | +4.0% | +10.7% | PGNY higher |
| Debt / equity as of 2026-08-11 | 0.69 | 0.00 | PGNY lower |
| Revenue growth (YoY) as of 2026-08-11 | +6.3% | +5.5% | ELV higher |
| Revenue CAGR (3y) SEC XBRL | +8.3% | +17.9% | PGNY higher |
| Dividend yield as of 2026-08-11 | +1.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-11 | 0.72 | 1.03 | |
| 1-year return as of 2026-08-10 close | +35.3% | +21.9% | ELV higher |
Fundamentals: market data, as of 2026-08-11. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.